Statistics

Total Visits

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)15

Select a period of time:

Number of views in the range

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)7

Views

Views
November 20231
December 20230
January 20242
February 20242
March 20240
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
 

Top cities views

Views
Ashburn2
Boardman1
Chicago1